Varex Imaging (VREX) Earnings Analysis
Varex Imaging (VREX) next reports earnings on 2026-08-06, consensus EPS 0.22 USD. Last quarter (2026-05-07) it missed with EPS 0.21 USD vs 0.22 USD est (-4.5%). It has beaten estimates in 4/6 recent quarters (67%). Trailing P/E -5.34.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does VREX next report earnings?
| Next earnings date | 2026-08-06 |
|---|---|
| Consensus EPS estimate | 0.22 USD |
| Revenue estimate | 0.22B |
VREX earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-07 | 0.21 USD | 0.22 USD | -4.5% | Miss |
| 2025-11-18 | 0.37 USD | 0.18 USD | +105.6% | Beat |
| 2025-08-07 | 0.18 USD | 0.04 USD | +350% | Beat |
| 2025-02-06 | 0.07 USD | 0.04 USD | +75% | Beat |
| 2024-11-19 | 0.19 USD | 0.09 USD | +111.1% | Beat |
| 2024-08-01 | 0.14 USD | 0.19 USD | -26.3% | Miss |
Beat rate: 4/6 (67%) over reported quarters with consensus data.
VREX valuation and analyst view
| Trailing P/E | -5.34 |
|---|---|
| Trailing EPS | -1.97375 USD |
| Price / book | 0.94 |
| Dividend yield | 0.00% |
| Market cap | 0.45B |
| Analyst consensus | Buy (4 buy / 2 hold / 0 sell) |
| Avg price target | 14.5 USD |
Related research pages
Frequently asked questions
When is Varex Imaging (VREX)'s next earnings date?
Varex Imaging is next scheduled to report on 2026-08-06, with a consensus EPS estimate of 0.22 USD and revenue estimate of 0.22B.
Did VREX beat earnings last quarter?
In its 2026-05-07 report, VREX posted EPS of 0.21 USD versus a 0.22 USD estimate — a miss of 4.5%.
What is VREX's earnings track record?
Over the last 6 reported quarters with consensus data, VREX beat estimates 4 times (67%).
What is VREX's current P/E ratio and EPS?
VREX trades at a trailing P/E of -5.34 on trailing EPS of -1.973747016706444 USD.
What do analysts rate VREX?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 4 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 14.5 USD.